190 related articles for article (PubMed ID: 9108417)
1. CD3- CD56+ non-Hodgkin's lymphomas with an aggressive behavior related to multidrug resistance.
Drénou B; Lamy T; Amiot L; Fardel O; Caulet-Maugendre S; Sasportes M; Diebold J; Le Prisé PY; Fauchet R
Blood; 1997 Apr; 89(8):2966-74. PubMed ID: 9108417
[TBL] [Abstract][Full Text] [Related]
2. Nasal and nasal-type T/NK-cell lymphoma with cutaneous involvement.
Kato N; Yasukawa K; Onozuka T; Kikuta H
J Am Acad Dermatol; 1999 May; 40(5 Pt 2):850-6. PubMed ID: 10321634
[TBL] [Abstract][Full Text] [Related]
3. Enteropathy-type T-cell lymphoma expressing NK-cell intraepithelial lymphocyte (NK-IEL) phenotype.
Inagaki N; Asaoka D; Mori KL; Sohda N; Miura I; Miwa H; Sato N; Oshimi K
Leuk Lymphoma; 2004 Jul; 45(7):1471-4. PubMed ID: 15359651
[TBL] [Abstract][Full Text] [Related]
4. Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm.
Chan JK; Sin VC; Wong KF; Ng CS; Tsang WY; Chan CH; Cheung MM; Lau WH
Blood; 1997 Jun; 89(12):4501-13. PubMed ID: 9192774
[TBL] [Abstract][Full Text] [Related]
5. CD5-CD56+ T-cell receptor silent peripheral T-cell lymphomas are natural killer cell lymphomas.
Emile JF; Boulland ML; Haioun C; Kanavaros P; Petrella T; Delfau-Larue MH; Bensussan A; Farcet JP; Gaulard P
Blood; 1996 Feb; 87(4):1466-73. PubMed ID: 8608237
[TBL] [Abstract][Full Text] [Related]
6. Nasal T/natural killer (NK)-cell lymphomas are derived from Epstein-Barr virus-infected cytotoxic lymphocytes of both NK- and T-cell lineage.
Chiang AK; Chan AC; Srivastava G; Ho FC
Int J Cancer; 1997 Nov; 73(3):332-8. PubMed ID: 9359478
[TBL] [Abstract][Full Text] [Related]
7. Extranodal multiple involvement of enteropathy-type T-cell lymphoma without expression of CC chemokine receptor 7.
Shiratsuchi M; Suehiro Y; Yoshikawa Y; Ohshima K; Shiokawa S; Nishimura J
Int J Hematol; 2004 Jan; 79(1):44-7. PubMed ID: 14979477
[TBL] [Abstract][Full Text] [Related]
8. CD8+, CD56+ (natural killer-like) T-cell lymphoma involving the small intestine with no evidence of enteropathy: clinicopathology and molecular study of five Japanese patients.
Akiyama T; Okino T; Konishi H; Wani Y; Notohara K; Tsukayama C; Tsunoda T; Tasaka T; Masaki Y; Sugihara T; Sadahira Y
Pathol Int; 2008 Oct; 58(10):626-34. PubMed ID: 18801082
[TBL] [Abstract][Full Text] [Related]
9. Establishment of an IL-2-dependent cell line derived from 'nasal-type' NK/T-cell lymphoma of CD2+, sCD3-, CD3epsilon+, CD56+ phenotype and associated with the Epstein-Barr virus.
Kagami Y; Nakamura S; Suzuki R; Iida S; Yatabe Y; Okada Y; Kobayashi T; Tsurumi T; Seto M; Ogura M; Taguchi O; Morishima Y
Br J Haematol; 1998 Dec; 103(3):669-77. PubMed ID: 9858215
[TBL] [Abstract][Full Text] [Related]
10. A cutaneous agranular CD2- CD4+ CD56+ "lymphoma": report of two cases and review of the literature.
Kameoka J; Ichinohasama R; Tanaka M; Miura I; Tomiya Y; Takahashi S; Yamada M; Ishikawa I; Kadowaki I; Sasaki O; Kimura J; Meguro K; Ooya K; Ito S
Am J Clin Pathol; 1998 Oct; 110(4):478-88. PubMed ID: 9763034
[TBL] [Abstract][Full Text] [Related]
11. [CD56- and CD4-positive non-Hodgkin's lymphoma of probable T-cell origin].
Honda S; Ito Y; Otawa M; Katagiri T; Kuriyama Y; Serizawa H; Ebihara Y; Mukai K; Ohyashiki K
Rinsho Ketsueki; 2001 May; 42(5):420-5. PubMed ID: 11452463
[TBL] [Abstract][Full Text] [Related]
12. T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases.
Coupland SE; Foss HD; Assaf C; Auw-Haedrich C; Anastassiou G; Anagnostopoulos I; Hummel M; Karesh JW; Lee WR; Stein H
Ophthalmology; 1999 Nov; 106(11):2109-20. PubMed ID: 10571346
[TBL] [Abstract][Full Text] [Related]
13. Influence of molecular characteristics on clinical outcome in human immunodeficiency virus-associated non-Hodgkin's lymphoma: identification of a subgroup with favorable clinical outcome.
Kaplan LD; Shiramizu B; Herndier B; Hahn J; Meeker TC; Ng V; Volberding PA; McGrath MS
Blood; 1995 Apr; 85(7):1727-35. PubMed ID: 7535586
[TBL] [Abstract][Full Text] [Related]
14. Natural killer-like T-cell lymphoma of the parotid in a patient infected with human immunodeficiency virus.
Cornfield DB; Papiez JS; Lynch JT; Rimsza LM
Arch Pathol Lab Med; 2002 Jun; 126(6):738-41. PubMed ID: 12033970
[TBL] [Abstract][Full Text] [Related]
15. Primary nasopharyngeal non-Hodgkin lymphoma and its relationship with Epstein-Barr virus infection.
Zhang B; Zong Y; He J; Zhong B; Lin S
Chin Med J (Engl); 2003 Jun; 116(6):913-7. PubMed ID: 12877806
[TBL] [Abstract][Full Text] [Related]
16. CD56-negative extranodal nasal type of natural killer/T-cell lymphoma with extranasal skin involvement.
Lan MX; Zhen ZX; Ming WH
Leuk Lymphoma; 2009 Oct; 50(10):1715-7. PubMed ID: 19863343
[No Abstract] [Full Text] [Related]
17. Involvement of the appendix in a relapsed case of primary nasal NK/T-cell lymphoma.
Tsujimura H; Takagi T; Tamaru J; Sakai C
Leuk Lymphoma; 2000 May; 37(5-6):633-4. PubMed ID: 11042526
[TBL] [Abstract][Full Text] [Related]
18. High grade malignant lymphoma with clinical characteristics and immunophenotype of natural killer cells.
Schleiffenbaum B; Rüegg R; Zimmermann D; Fehr J
Am J Hematol; 1995 Jul; 49(3):221-31. PubMed ID: 7541603
[TBL] [Abstract][Full Text] [Related]
19. Hodgkin's disease following extranodal marginal zone B-cell lymphoma in remission.
Shimizu K; Hara K; Yatabe Y
Int J Hematol; 1999 Feb; 69(2):96-100. PubMed ID: 10071458
[TBL] [Abstract][Full Text] [Related]
20. Practicability and acute haematological toxicity of 2- and 3-weekly CHOP and CHOEP chemotherapy for aggressive non-Hodgkin's lymphoma: results from the NHL-B trial of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL).
Wunderlich A; Kloess M; Reiser M; Rudolph C; Truemper L; Bittner S; Schmalenberg H; Schmits R; Pfreundschuh M; Loeffler M;
Ann Oncol; 2003 Jun; 14(6):881-93. PubMed ID: 12796026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
